AbCellera Biologics Earnings
NASDAQ: ABCLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
12.55+0.525 (+4.37%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
AbCellera Biologics earnings summary
In its most recent report on Aug 5, 2026 (Q2 2026), ABCL posted EPS of $-0.18. Revenue for the quarter was $4.0 million. Across the last 16 reports, ABCL shares moved an average of 10.0% (in either direction) in the first trading session after results, rising 6 times and falling 9 times.
Summary generated from market data by MetaCap's automated system. Methodology
ABCL earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $-0.18 | — | +64.2% |
| May 11, 2026 | — | $-0.14 | — | +27.1% |
| Feb 24, 2026 | — | $-0.03 | — | -4.4% |
| Nov 6, 2025 | — | $-0.19 | — | -5.6% |
| Aug 7, 2025 | — | $-0.12 | — | +8.0% |
| May 8, 2025 | — | $-0.15 | — | 0.0% |
| Feb 27, 2025 | — | $-0.11 | — | -9.9% |
| Nov 4, 2024 | — | $-0.17 | — | -1.9% |
| Aug 6, 2024 | — | $-0.13 | — | -2.6% |
| May 7, 2024 | — | $-0.14 | — | -5.0% |
| Feb 20, 2024 | — | $-0.16 | — | +3.7% |
| Nov 2, 2023 | — | $-0.10 | — | -14.0% |
| Aug 3, 2023 | — | $-0.11 | — | -4.6% |
| May 4, 2023 | — | $-0.14 | — | -4.2% |
| Feb 21, 2023 | — | $-0.10 | — | +0.1% |
| Nov 8, 2022 | — | $0.08 | — | +4.3% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.